e-SPACE Cardio-Renal-Metabolic 2024
Published: 29 March 2024
-
Views:
489 -
Likes:
7
-
Views:
489 -
Likes:
7
-
Up Next
-
57m 21s
-
1h 7sPart 1 | Session 6 Plenary Session 5 – CRM disease: epidemiology and pathophysiology
-
54m 56sPart 2 | Session 1 Plenary Session 6 – Anaemia and iron deficiency
-
16m 6s
-
1h 10s
-
1h 8m 49sPart 2 | Session 4 Plenary Session 8 – Early intervention and intensive management
-
27m 17sPart 2 | Session 5 Effects of GLP- 1RA on kidney outcomes in CKD and T2D
-
1h 3m 47sPart 2 | Session 6 Plenary Session 9 – Precision medicine in CRM
-
1h 6sPart 1 | Session 1 Plenary Session 1 – Multidisciplinary implementation strategies Gerasimos Filippatos, Manisha Sahay, Gianluigi Savarese, Francesco Cosentino, Sam Seidu
-
28m 56sPart 1 | Session 2 Keynote Session – KDIGO guideline updates 2024 Paul Stevens
-
1h 2m 27sPart 1 | Session 3 Plenary Session 2 – Guideline directed therapy for CRM disease: the evidence base Intissar Haddiya, Lars H Lund, Marco Metra, Nikolaus Marx, Peter Rossing, Giuseppe Rosano
Overview
KDIGO and Translational Medicine Academy (TMA) in partnership with Radcliffe Cardiology were delighted to announce the return of e-SPACE Cardio-Renal-Metabolic (CRM) 2024.
A thoughtfully curated programme supported the exploration of how leading experts, in cardiology, nephrology and diabetology, treat the interrelated diseases.
This event once again brought together TMA’s mandate for the delivery of continuing professional development to healthcare professionals to achieve concordance with appropriate treatment plans, alongside KDIGO's mission to improve the care and outcomes of patients with kidney disease worldwide through the development and implementation of global clinical practice guidelines, with Radcliffe Cardiology’s goal to deliver cardiovascular knowledge to best support cardiovascular communities transform theory into practice.
Related sessions to e-SPACE Cardio-Renal-Metabolic 2024:
Learning Objectives
- Review the burden of diabetes, kidney disease and heart failure including morbidity, excess mortality and reduced quality of life affecting individuals around the world
- Describe the complexity and interlink between the three conditions
- Discuss existing guidelines and best approaches for screening patients
- Review evidence-based management strategies for diabetes, cardiovascular disease, heart failure, kidney disease and obesity including SLGT2i, GLP-1RA, new non-steroidal mineralocorticoid receptor antagonists and other emerging therapies
- Foster cross-collaboration between other cardiorenal / metabolic specialists and primary care physicians and allied health care professionals in order to improve patients outcomes
Target Audience
- Cardiologists
- Nephrologists
- Diabetologists
- General Practitioners (GPs)
- HF Specialists
- Nurses, Pharmacists, and other Allied Healthcare Professionals
More from this programme
Part 1
Day One
Part 2
Day Two
Faculty Biographies
Gianluigi Savarese
Associate Professor of Cardiology
Prof Gianluigi Savarese is currently an Associate Professor of Cardiology and Heart Failure Specialist at the Karolinska Institute in Stockholm, Sweden.
Prof Savarese has served on the board for the European Society of Cardiology's Heart Failure Association since 2020, and has previously been a Nucleus member of a working group on Cardiovascular Pharmacotherapy for the ESC. He is a member of the Italian Society of Cardiology, and the Swedish Society of Cardiology.
Prof Savarese attended the University of Naples Federico II University for his degree in Surgery and Medicine between 2004 - 2010. He then went on to stay at the same institution until 2016 as he completed his Specialism in Cardiovascular Diseases. He then continued his postgraduate studies at the University of Zurich between 2015-2017, where he continued his studies into Heart Failure. Finally, Prof Savarese completed his PhD at the Karolinska Institutet in 2018.
Prof Savarese has…
Alice Cheng
Endocrinologist
Dr Alice Cheng is an Associate Professor at University of Toronto, Toronto, CA and Endocrinologist at Trillium Health Partners.
Dr Cheng has been involved with the development of the Diabetes Canada clinical practice guidelines since 2003 and served as Chair for the 2013 version.
Dr Adeera Levin
Dr. Adeera Levin is a Professor of Medicine, Head Division of Nephrology at the University of British Columbia, and Consultant nephrologist at Providence Health Care/ St Paul’s Hospital, in Vancouver Canada. She is also the Executive Director of the BC Renal Agency, which oversees the care, planning and budgets for Kidney services in the province of British Columbia. In this capacity, Dr. Levin has leveraged her epidemiological training, clinical knowledge, and health outcomes research to develop an evidence-based transparent system which enhances the care of patients across the continuum of care (from identification of chronic kidney disease [CKD] through to dialysis, transplant, and death).
Antonio Ceriello
Head of Diabetes Department
Prof Antonio Ceriello is Head of Diabetes Department at IRCCS MultiMedica, Milan, IT.
He has chaired the International Diabetes Federation (IDF) committee for the development in 2008, and in the 2011 for the update of “Guideline for Management of Postmeal Glucose".
Prof Ceriello has been a Member of the Board for the development of the new “European Society of Cardiology (ESC) guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD".
He has published over 450 original papers.
Shelley Zieroth
Director, Heart Failure and Heart Transplant Clinics
Dr Shelley Zieroth is Professor at the College of Medicine, Max Rady Faculty of Health Sciences, University of Manitoba, as well as Director of the Heart Failure and Heart Transplant Clinics at St Boniface Hospital in Winnipeg, Canada. She is also Head of the Medical Heart Failure Program for Cardiac Sciences Manitoba.
She is involved in several heart failure clinical trials as a PI, National Lead or Executive Committee member. She is the Past President of the Canadian Heart Failure Society and Co-Chair of the Canadian Cardiovascular Society Heart Failure Guidelines. She is co-chair of Canada’s largest annual heart failure meeting, HF Update, and Past President of the Federation of Medical Women of Canada.
Dr Shelley Zieroth is an Editorial Board member of Cardiac Failure Review.
Giuseppe Rosano
Consultant Cardiologist and Professor of Cardiology (Hon)
Giuseppe Rosano is Consultant Cardiologist and Professor of Cardiology at St George’s, University of London, UK where he is also the director of MSc Heart Failure.
Prof Rosano's areas of expertise include heart failure, cardiac metabolism, cardiovascular pharmacology and pharmacotherapy, heart disease in women and cardiovascular effects of sex hormones. He has a specific interest in chronic coronary syndromes and in angina with normal coronary arteries.
Prof Rosano has been core member of the Cardiovascular Working Party of the European Medicines Agency and member of the Pricing and Reimbursement Committee of the Italian…
Comments